Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
NCT07287917
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-low Hormone Receptor Positive Breast Cancer, +13 more
- Locations
-
- University of Arizona Tucson, Arizona, United States
- START Los Angeles Los Angeles, California, United States
- Skin Cancer Institute Englewood, Colorado, United States
- Wayne State University - Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States